NCT04467697 Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men Status COMPLETED Phase PHASE3
NCT04276558 REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients Status COMPLETED Phase PHASE2
NCT04204252 Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation" Status RECRUITING Phase PHASE3
NCT04068259 Single Ascending Dose Study of PBI-4547 in Healthy Subjects Status TERMINATED Phase PHASE1
NCT04021563 The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04020016 Study of Nalbuphine ER in Participants With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT03990883 Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF) Status COMPLETED Phase NA
NCT03888066 Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) Status COMPLETED Phase PHASE3
NCT03869983 Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection and Omnipaque™ Injection Status COMPLETED Phase NA
NCT03844191 A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4 Status COMPLETED Phase PHASE1
NCT03832946 A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT03824795 Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD Status COMPLETED Phase PHASE2
NCT03776539 A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02 Status COMPLETED Phase PHASE1
NCT03765671 Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients Status COMPLETED Phase PHASE1
NCT03719612 DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY Status COMPLETED Phase PHASE3
NCT03710694 Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI) Status COMPLETED Phase NA
NCT03652051 A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED) Status COMPLETED Phase PHASE2
NCT03636347 A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. Status COMPLETED Phase PHASE2